Speciality Medicines IPO Details
The Speciality Medicines IPO is a book build issue with a total issue size of ₹29 cr, comprising of fresh issue of 2200000 equity shares. Speciality Medicines IPO opened for subscription on Mar 20, 2026 and closed on Mar 24, 2026. Speciality Medicines IPO is set price band at ₹117 to ₹124 per share, with a lot size of 1000 shares. Minimum investment for Retail investors was ₹248,000.00 (at the upper price band) to apply for one lot.
The basis of allotment got finalized on Mar 25, 2026, and listed on both the NSE and BSE on Mar 30, 2026.
Skyline Financial Services Private Ltd has been appointed as the registrar. Unistone Capital Pvt Ltd are the Book Running Lead Manager for the issue.
Before investing in the Speciality Medicines IPO, investors should review the company's financial performance, business objectives, and risk factors mentioned in the offer documents and apply before the subscription window closes.
- Price Band
- ₹ 117 – 124
- Lot Size
- 1000
- Issue Size
- ₹29 Cr
- Minimum Investment
- ₹248000 (2000 Shares)
- Listing Date
- 30 March 2026
Current GMP
₹0 (0.00%)
*Info is indicative. Not an Investment Advice. Grey market trading is unregulated.
About Speciality Medicines Limited
Incorporated in 2021, Speciality Medicines Limited operates in the marketing and distribution of specialty pharmaceutical formulations. The company focuses on high-value oral and injectable medicines used in the treatment of complex and chronic health conditions.
Its product portfolio includes a diverse range of finished formulations available in multiple dosage forms such as tablets, capsules, creams, syrups, eye drops, gels, infusions, inhalers, injections, nasal sprays, ointments, ophthalmic solutions, oral solutions, sachets, and suspensions.
The company follows a dual business model:
- Contract Manufacturing: Manufacturing finished pharmaceutical formulations for international markets.
- Marketing and Distribution: Sourcing, marketing, and distributing specialty pharmaceutical products across domestic and global markets.
Speciality Medicines Limited has established an expanding international presence, with product registrations (approved and under process) in countries including Jordan, Ethiopia, Uganda, Peru, and Namibia. The company has built a strong distribution network spanning over 20 states in India and more than 35 countries worldwide.
As of March 31, 2025, the company had 1 product registered overseas and 60 products under registration across five countries, contributing to its revenue pipeline.
As of August 31, 2025, the company employed 18 permanent staff across various functional departments.
Speciality Medicines IPO Promoters
- Parth B Goyani
- Goyani Sumit Babubhai
Promoters Holding
Holding Pre Issue
59.67%
Holding Post Issue
0.00%
Speciality Medicines IPO Objective
The Company Speciality Medicines IPO proposes to utilise the Net Proceeds from the Issue towards the following objects.
- Setting up of Research and Development (R&D) Center
- Product registration in the international markets
- Repayment/ prepayment, in full or part, of certain borrowings availed by our Company
- To Meet Working Capital Requirements
- General Corporate Purposes
Address / Contact Info
Speciality Medicines Ltd.
913, One World West, S. No. 396, FP 119,
Village- Vejalpur, Ahmadabad City,
Ahmedabad, Gujarat, India,
Ahmedabad, Gujarat, 380051
Phone: +91 22 4604 5344
Email: investors.grievances@specialitymedicine.com
Website: http://www.specialitymedicine.com/
IPO Snapshot
Book Running Lead Managers
- Unistone Capital Pvt Ltd
Disclaimer: This data is for informational purposes only and does not constitute investment advice. Figures shown are illustrative sample data.
Frequently Asked Questions
Everything you need to know before applying to an IPO.
Speciality Medicines IPO is a Book-building IPO with a total issue size of ₹29 crore. The Speciality Medicines IPO price band is ₹117 to 124 per share. The Speciality Medicines IPO subscription opens on Fri, Mar 20, 2026, and closes on Tue, Mar 24, 2026. The Speciality Medicines IPO will be listed on the BSE. Skyline Financial Services Private Ltd is the registrar for the Speciality Medicines IPO.
The Speciality Medicines IPO opens on Fri, Mar 20, 2026 and closes on Tue, Mar 24, 2026
Speciality Medicines IPO Price Band is ₹117 to 124 per share.
Speciality Medicines IPO lot size is 1000 shares, Retail investors need a minimum investment of ₹248000 based on the upper price band
The minimum investment for Speciality Medicines IPO is ₹248000, based on one lot of 1000 shares at the upper price band of ₹124 per share.
Investors can apply for the Speciality Medicines IPO through the ASBA (Application Supported by Blocked Amount) facility offered by their bank or through UPI using a SEBI-registered broker or trading app. Select the desired lot size, enter your bid within the price band, and submit the application before Tue, Mar 24, 2026. The application amount remains blocked until the Speciality Medicines IPO allotment is finalized.
Speciality Medicines IPO issue size is ₹29 crores.
Speciality Medicines IPO allotment date is Wed, Jul 1, 2026.
The registrar for Speciality Medicines IPO is Skyline Financial Services Private Ltd. Investors can go to Skyline Financial Services Private Ltd website to check Speciality Medicines IPO allotment status, refund processing, and other IPO-related information.